Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups.
Serge BovedaLucas HigueraColleen F LongacreClaudia WolffKael S WherryKurt StrombergMikhael F El-ChamiPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
ClinicalTrials.gov ID NCT03039712.